FAAS
ALXN

First Allied Advisory Services’s Alexion Pharmaceuticals ALXN Stock Holding History

First Allied Advisory Services’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$732K Sell
6,400
-1,711
-21% -$185K 0.02% 577
2020
Q2 		$910K Sell
8,111
-4,856
-37% -$516K 0.03% 465
2020
Q1 		$1.16M Buy
12,967
+5,160
+66% +$506K 0.05% 361
2019
Q4 		$845K Buy
7,807
+4,812
+161% +$515K 0.03% 535
2019
Q3 		$295K Buy
+2,995
New +$338K 0.01% 904
2016
Q1 		– Sell
-1,083
Closed -$205K – 1140
2015
Q4 		$205K Buy
+1,083
New +$189K 0.01% 961

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return